(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.02%) $0.927
(0.21%) $10.86
(0.01%) $0.792
(0.00%) $92.57
-3.23% HKD 0.0300
Live Chart Being Loaded With Signals
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China...
Stats | |
---|---|
Today's Volume | 40 000.00 |
Average Volume | 716 612 |
Market Cap | 71.70M |
EPS | HKD0 ( 2023-11-29 ) |
Last Dividend | HKD0 ( N/A ) |
Next Dividend | HKD0 ( N/A ) |
P/E | -0.430 |
ATR14 | HKD0 (0.00%) |
Extrawell Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Extrawell Pharmaceutical Financials
Annual | 2022 |
Revenue: | HKD72.58M |
Gross Profit: | HKD31.14M (42.91 %) |
EPS: | HKD0.0541 |
Q2 | 2023 |
Revenue: | HKD30.14M |
Gross Profit: | HKD14.89M (49.40 %) |
EPS: | HKD-0.0995 |
Q4 | 2022 |
Revenue: | HKD38.48M |
Gross Profit: | HKD17.61M (45.76 %) |
EPS: | HKD0.0349 |
Q3 | 2022 |
Revenue: | HKD19.24M |
Gross Profit: | HKD8.81M (45.76 %) |
EPS: | HKD0.0127 |
Financial Reports:
No articles found.
Extrawell Pharmaceutical
Extrawell Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, distributes, and sells pharmaceutical products in the People's Republic of China. The company operates through Manufacturing, Trading, and Gene Development segments. It offers transfer factor oral solution, a dual immune regulator for the treatment of diseases caused by virus infection and weak cellular immune system; and Wisk for the treatment of II-III degree of radio-injury of skin, normal common burn, actinic dermatitis, various infectious ulcers, and oral ulcers, as well as for trauma and post operation wound healing. The company also provides ZhouBang, a thromboxane synthetase inhibitor to prevent the coagulation of platelets and facilitate relaxation of blood vessels. In addition, it is involved in the marketing and distribution of imported pharmaceutical products, including Millibar for the treatment of high blood pressure; and development of oral insulin. Further, the company engages in the commercial exploitation and development of genome-related technology; provision of agency services; property investment business; and holding of gene invention rights. Extrawell Pharmaceutical Holdings Limited is headquartered in Quarry Bay, Hong Kong.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators